Medical experts in Sheffield have hailed as a "game changer" trials of a drug that could reduce the recurrence of bladder ...
Over the coming months, it is anticipated Pluvicto will be available for eligible patients at most of Ontario’s Cancer ...
Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...
R-5780, an oral immuno-oncology drug designed to activate gut-regulated immune pathways, will now be evaluated in a phase 1 ...
Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, ...
The Food and Drug Administration has accepted and granted priority review to a new drug application for sunvozertinib.
A research team at Memorial Sloan Kettering Cancer Center (MSK) has made new insights into how the body forms immune cell ...
News Medical on MSN5h
CAR-NK cells offer safer, more accessible treatment for lymphomaA new type of cell-based immunotherapy shows promise for B-cell lymphomas and - due to innovations in manufacturing - could make future cellular immunotherapies less expensive and more accessible to ...
The New Brunswick, N.J., pharmaceutical giant said the FDA accepted the application through its Real-Time Oncology Review program, which allows for an earlier submission of topline efficacy and safety ...
Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market ...
THE CHOSUNILBO on MSN11h
South Korea’s FDA-approved Leclaza offers breakthrough in lung cancer survivalSouth Korea’s first domestically developed anti-cancer drug approved by the U.S. Food and Drug Administration (FDA), has ...
Radiotherapy is a cornerstone of cancer care. However, in recent decades, Sweden has fallen behind in this area, both in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback